A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_sessionadec07a92722fa7cb5ffb94c4bc27ea18570a667): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Primary Hepatocytes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

img

Global Primary Hepatocytes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Primary Hepatocytes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Primary Hepatocytes report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Primary Hepatocytes market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Life Science Research Companies and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Primary Hepatocytes industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Primary Hepatocytes key manufacturers include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc. Thermo Fisher Scientific, Inc., Merck KGaA, Lonza are top 3 players and held % sales share in total in 2022.
Primary Hepatocytes can be divided into Human Primary Cells and Animal Primary Cells, etc. Human Primary Cells is the mainstream product in the market, accounting for % sales share globally in 2022.
Primary Hepatocytes is widely used in various fields, such as Life Science Research Companies, Research Institutes and Others,, etc. Life Science Research Companies provides greatest supports to the Primary Hepatocytes industry development. In 2022, global % sales of Primary Hepatocytes went into Life Science Research Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Primary Hepatocytes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza
Cell Biologics, Inc.
PromoCell GmbH
HemaCare Corporation
ZenBio, Inc.
STEMCELL Technologies, Inc.
Corning Incorporated
AllCells
Axol Bioscience Ltd.
iXCells Biotechnologies
Neuromics
StemExpress
BioIVT
ScienCell Research Laboratories, Inc.
PPA Research Group, Inc.
Creative Bioarray
BPS Bioscience, Inc.
Epithelix Sàrl
ReachBio LLC
AcceGen
Sekisui XenoTech, LLC
Biopredic International
Segment by Type
Human Primary Cells
Animal Primary Cells

Segment by Application


Life Science Research Companies
Research Institutes
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Primary Hepatocytes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Primary Hepatocytes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Primary Hepatocytes industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Primary Hepatocytes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Primary Hepatocytes introduction, etc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Primary Hepatocytes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Primary Hepatocytes Market Overview
1.1 Primary Hepatocytes Product Overview
1.2 Primary Hepatocytes Market Segment by Type
1.2.1 Human Primary Cells
1.2.2 Animal Primary Cells
1.3 Global Primary Hepatocytes Market Size by Type
1.3.1 Global Primary Hepatocytes Market Size Overview by Type (2018-2033)
1.3.2 Global Primary Hepatocytes Historic Market Size Review by Type (2018-2023)
1.3.3 Global Primary Hepatocytes Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.2 Europe Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Primary Hepatocytes Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Primary Hepatocytes Sales Breakdown by Type (2018-2023)
2 Global Primary Hepatocytes Market Competition by Company
2.1 Global Top Players by Primary Hepatocytes Sales (2018-2023)
2.2 Global Top Players by Primary Hepatocytes Revenue (2018-2023)
2.3 Global Top Players by Primary Hepatocytes Price (2018-2023)
2.4 Global Top Manufacturers Primary Hepatocytes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Primary Hepatocytes Market Competitive Situation and Trends
2.5.1 Primary Hepatocytes Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Primary Hepatocytes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primary Hepatocytes as of 2022)
2.7 Date of Key Manufacturers Enter into Primary Hepatocytes Market
2.8 Key Manufacturers Primary Hepatocytes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Primary Hepatocytes Status and Outlook by Region
3.1 Global Primary Hepatocytes Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Primary Hepatocytes Historic Market Size by Region
3.2.1 Global Primary Hepatocytes Sales in Volume by Region (2018-2023)
3.2.2 Global Primary Hepatocytes Sales in Value by Region (2018-2023)
3.2.3 Global Primary Hepatocytes Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Primary Hepatocytes Forecasted Market Size by Region
3.3.1 Global Primary Hepatocytes Sales in Volume by Region (2024-2033)
3.3.2 Global Primary Hepatocytes Sales in Value by Region (2024-2033)
3.3.3 Global Primary Hepatocytes Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Primary Hepatocytes by Application
4.1 Primary Hepatocytes Market Segment by Application
4.1.1 Life Science Research Companies
4.1.2 Research Institutes
4.1.3 Others
4.2 Global Primary Hepatocytes Market Size by Application
4.2.1 Global Primary Hepatocytes Market Size Overview by Application (2018-2033)
4.2.2 Global Primary Hepatocytes Historic Market Size Review by Application (2018-2023)
4.2.3 Global Primary Hepatocytes Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.2 Europe Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Primary Hepatocytes Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Primary Hepatocytes Sales Breakdown by Application (2018-2023)
5 North America Primary Hepatocytes by Country
5.1 North America Primary Hepatocytes Historic Market Size by Country
5.1.1 North America Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Primary Hepatocytes Sales in Volume by Country (2018-2023)
5.1.3 North America Primary Hepatocytes Sales in Value by Country (2018-2023)
5.2 North America Primary Hepatocytes Forecasted Market Size by Country
5.2.1 North America Primary Hepatocytes Sales in Volume by Country (2024-2033)
5.2.2 North America Primary Hepatocytes Sales in Value by Country (2024-2033)
6 Europe Primary Hepatocytes by Country
6.1 Europe Primary Hepatocytes Historic Market Size by Country
6.1.1 Europe Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Primary Hepatocytes Sales in Volume by Country (2018-2023)
6.1.3 Europe Primary Hepatocytes Sales in Value by Country (2018-2023)
6.2 Europe Primary Hepatocytes Forecasted Market Size by Country
6.2.1 Europe Primary Hepatocytes Sales in Volume by Country (2024-2033)
6.2.2 Europe Primary Hepatocytes Sales in Value by Country (2024-2033)
7 Asia-Pacific Primary Hepatocytes by Region
7.1 Asia-Pacific Primary Hepatocytes Historic Market Size by Region
7.1.1 Asia-Pacific Primary Hepatocytes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Primary Hepatocytes Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Primary Hepatocytes Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Primary Hepatocytes Forecasted Market Size by Region
7.2.1 Asia-Pacific Primary Hepatocytes Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Primary Hepatocytes Sales in Value by Region (2024-2033)
8 Latin America Primary Hepatocytes by Country
8.1 Latin America Primary Hepatocytes Historic Market Size by Country
8.1.1 Latin America Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Primary Hepatocytes Sales in Volume by Country (2018-2023)
8.1.3 Latin America Primary Hepatocytes Sales in Value by Country (2018-2023)
8.2 Latin America Primary Hepatocytes Forecasted Market Size by Country
8.2.1 Latin America Primary Hepatocytes Sales in Volume by Country (2024-2033)
8.2.2 Latin America Primary Hepatocytes Sales in Value by Country (2024-2033)
9 Middle East and Africa Primary Hepatocytes by Country
9.1 Middle East and Africa Primary Hepatocytes Historic Market Size by Country
9.1.1 Middle East and Africa Primary Hepatocytes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Primary Hepatocytes Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Primary Hepatocytes Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Primary Hepatocytes Forecasted Market Size by Country
9.2.1 Middle East and Africa Primary Hepatocytes Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Primary Hepatocytes Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.1.1 Thermo Fisher Scientific, Inc. Company Information
10.1.2 Thermo Fisher Scientific, Inc. Introduction and Business Overview
10.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Thermo Fisher Scientific, Inc. Primary Hepatocytes Products Offered
10.1.5 Thermo Fisher Scientific, Inc. Recent Development
10.2 Merck KGaA
10.2.1 Merck KGaA Company Information
10.2.2 Merck KGaA Introduction and Business Overview
10.2.3 Merck KGaA Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck KGaA Primary Hepatocytes Products Offered
10.2.5 Merck KGaA Recent Development
10.3 Lonza
10.3.1 Lonza Company Information
10.3.2 Lonza Introduction and Business Overview
10.3.3 Lonza Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lonza Primary Hepatocytes Products Offered
10.3.5 Lonza Recent Development
10.4 Cell Biologics, Inc.
10.4.1 Cell Biologics, Inc. Company Information
10.4.2 Cell Biologics, Inc. Introduction and Business Overview
10.4.3 Cell Biologics, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cell Biologics, Inc. Primary Hepatocytes Products Offered
10.4.5 Cell Biologics, Inc. Recent Development
10.5 PromoCell GmbH
10.5.1 PromoCell GmbH Company Information
10.5.2 PromoCell GmbH Introduction and Business Overview
10.5.3 PromoCell GmbH Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 PromoCell GmbH Primary Hepatocytes Products Offered
10.5.5 PromoCell GmbH Recent Development
10.6 HemaCare Corporation
10.6.1 HemaCare Corporation Company Information
10.6.2 HemaCare Corporation Introduction and Business Overview
10.6.3 HemaCare Corporation Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 HemaCare Corporation Primary Hepatocytes Products Offered
10.6.5 HemaCare Corporation Recent Development
10.7 ZenBio, Inc.
10.7.1 ZenBio, Inc. Company Information
10.7.2 ZenBio, Inc. Introduction and Business Overview
10.7.3 ZenBio, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ZenBio, Inc. Primary Hepatocytes Products Offered
10.7.5 ZenBio, Inc. Recent Development
10.8 STEMCELL Technologies, Inc.
10.8.1 STEMCELL Technologies, Inc. Company Information
10.8.2 STEMCELL Technologies, Inc. Introduction and Business Overview
10.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.8.4 STEMCELL Technologies, Inc. Primary Hepatocytes Products Offered
10.8.5 STEMCELL Technologies, Inc. Recent Development
10.9 Corning Incorporated
10.9.1 Corning Incorporated Company Information
10.9.2 Corning Incorporated Introduction and Business Overview
10.9.3 Corning Incorporated Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Corning Incorporated Primary Hepatocytes Products Offered
10.9.5 Corning Incorporated Recent Development
10.10 AllCells
10.10.1 AllCells Company Information
10.10.2 AllCells Introduction and Business Overview
10.10.3 AllCells Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.10.4 AllCells Primary Hepatocytes Products Offered
10.10.5 AllCells Recent Development
10.11 Axol Bioscience Ltd.
10.11.1 Axol Bioscience Ltd. Company Information
10.11.2 Axol Bioscience Ltd. Introduction and Business Overview
10.11.3 Axol Bioscience Ltd. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Axol Bioscience Ltd. Primary Hepatocytes Products Offered
10.11.5 Axol Bioscience Ltd. Recent Development
10.12 iXCells Biotechnologies
10.12.1 iXCells Biotechnologies Company Information
10.12.2 iXCells Biotechnologies Introduction and Business Overview
10.12.3 iXCells Biotechnologies Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.12.4 iXCells Biotechnologies Primary Hepatocytes Products Offered
10.12.5 iXCells Biotechnologies Recent Development
10.13 Neuromics
10.13.1 Neuromics Company Information
10.13.2 Neuromics Introduction and Business Overview
10.13.3 Neuromics Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Neuromics Primary Hepatocytes Products Offered
10.13.5 Neuromics Recent Development
10.14 StemExpress
10.14.1 StemExpress Company Information
10.14.2 StemExpress Introduction and Business Overview
10.14.3 StemExpress Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.14.4 StemExpress Primary Hepatocytes Products Offered
10.14.5 StemExpress Recent Development
10.15 BioIVT
10.15.1 BioIVT Company Information
10.15.2 BioIVT Introduction and Business Overview
10.15.3 BioIVT Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.15.4 BioIVT Primary Hepatocytes Products Offered
10.15.5 BioIVT Recent Development
10.16 ScienCell Research Laboratories, Inc.
10.16.1 ScienCell Research Laboratories, Inc. Company Information
10.16.2 ScienCell Research Laboratories, Inc. Introduction and Business Overview
10.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.16.4 ScienCell Research Laboratories, Inc. Primary Hepatocytes Products Offered
10.16.5 ScienCell Research Laboratories, Inc. Recent Development
10.17 PPA Research Group, Inc.
10.17.1 PPA Research Group, Inc. Company Information
10.17.2 PPA Research Group, Inc. Introduction and Business Overview
10.17.3 PPA Research Group, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.17.4 PPA Research Group, Inc. Primary Hepatocytes Products Offered
10.17.5 PPA Research Group, Inc. Recent Development
10.18 Creative Bioarray
10.18.1 Creative Bioarray Company Information
10.18.2 Creative Bioarray Introduction and Business Overview
10.18.3 Creative Bioarray Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Creative Bioarray Primary Hepatocytes Products Offered
10.18.5 Creative Bioarray Recent Development
10.19 BPS Bioscience, Inc.
10.19.1 BPS Bioscience, Inc. Company Information
10.19.2 BPS Bioscience, Inc. Introduction and Business Overview
10.19.3 BPS Bioscience, Inc. Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.19.4 BPS Bioscience, Inc. Primary Hepatocytes Products Offered
10.19.5 BPS Bioscience, Inc. Recent Development
10.20 Epithelix Sàrl
10.20.1 Epithelix Sàrl Company Information
10.20.2 Epithelix Sàrl Introduction and Business Overview
10.20.3 Epithelix Sàrl Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Epithelix Sàrl Primary Hepatocytes Products Offered
10.20.5 Epithelix Sàrl Recent Development
10.21 ReachBio LLC
10.21.1 ReachBio LLC Company Information
10.21.2 ReachBio LLC Introduction and Business Overview
10.21.3 ReachBio LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.21.4 ReachBio LLC Primary Hepatocytes Products Offered
10.21.5 ReachBio LLC Recent Development
10.22 AcceGen
10.22.1 AcceGen Company Information
10.22.2 AcceGen Introduction and Business Overview
10.22.3 AcceGen Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.22.4 AcceGen Primary Hepatocytes Products Offered
10.22.5 AcceGen Recent Development
10.23 Sekisui XenoTech, LLC
10.23.1 Sekisui XenoTech, LLC Company Information
10.23.2 Sekisui XenoTech, LLC Introduction and Business Overview
10.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Sekisui XenoTech, LLC Primary Hepatocytes Products Offered
10.23.5 Sekisui XenoTech, LLC Recent Development
10.24 Biopredic International
10.24.1 Biopredic International Company Information
10.24.2 Biopredic International Introduction and Business Overview
10.24.3 Biopredic International Primary Hepatocytes Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Biopredic International Primary Hepatocytes Products Offered
10.24.5 Biopredic International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Primary Hepatocytes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Primary Hepatocytes Industrial Chain Analysis
11.4 Primary Hepatocytes Market Dynamics
11.4.1 Primary Hepatocytes Industry Trends
11.4.2 Primary Hepatocytes Market Drivers
11.4.3 Primary Hepatocytes Market Challenges
11.4.4 Primary Hepatocytes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Primary Hepatocytes Distributors
12.3 Primary Hepatocytes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Human Primary Cells
Table 2. Major Company of Animal Primary Cells
Table 3. Global Primary Hepatocytes Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 5. Global Primary Hepatocytes Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Primary Hepatocytes Sales by Type (2018-2023) & (US& Million)
Table 7. Global Primary Hepatocytes Market Share in Value by Type (2018-2023)
Table 8. Global Primary Hepatocytes Price by Type (2018-2023) & (USD/MT)
Table 9. Global Primary Hepatocytes Sales by Type (2024-2033) & (K MT)
Table 10. Global Primary Hepatocytes Sales Market Share in Volume by Type (2024-2033)
Table 11. Global Primary Hepatocytes Sales by Type (2024-2033) & (US$ Million)
Table 12. Global Primary Hepatocytes Sales Market Share in Value by Type (2024-2033)
Table 13. Global Primary Hepatocytes Price by Type (2024-2033) & (USD/MT)
Table 14. North America Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 15. North America Primary Hepatocytes Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Primary Hepatocytes Sales (K MT) by Type (2018-2023)
Table 17. Europe Primary Hepatocytes Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Primary Hepatocytes Sales (K MT) by Type (2018-2023)
Table 19. Asia-Pacific Primary Hepatocytes Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Primary Hepatocytes Sales (K MT) by Type (2018-2023)
Table 21. Latin America Primary Hepatocytes Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Primary Hepatocytes Sales (K MT) by Type (2018-2023)
Table 23. Middle East and Africa Primary Hepatocytes Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Primary Hepatocytes Sales by Company (2018-2023) & (K MT)
Table 25. Global Primary Hepatocytes Sales Share by Company (2018-2023)
Table 26. Global Primary Hepatocytes Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Primary Hepatocytes Revenue Share by Company (2018-2023)
Table 28. Global Market Primary Hepatocytes Price by Company (2018-2023) & (USD/MT)
Table 29. Global Primary Hepatocytes Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Primary Hepatocytes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Primary Hepatocytes as of 2022)
Table 32. Date of Key Manufacturers Enter into Primary Hepatocytes Market
Table 33. Key Manufacturers Primary Hepatocytes Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Primary Hepatocytes Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global Primary Hepatocytes Sales by Region (2018-2023) & (K MT)
Table 37. Global Primary Hepatocytes Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Primary Hepatocytes Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Primary Hepatocytes Sales Market Share in Value by Region (2018-2023)
Table 40. Global Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 41. Global Primary Hepatocytes Sales by Region (2024-2033) & (K MT)
Table 42. Global Primary Hepatocytes Sales Market Share in Volume by Region (2024-2033)
Table 43. Global Primary Hepatocytes Sales by Region (2024-2033) & (US$ Million)
Table 44. Global Primary Hepatocytes Sales Market Share in Value by Region (2024-2033)
Table 45. Global Primary Hepatocytes Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2033)
Table 46. Global Primary Hepatocytes Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 48. Global Primary Hepatocytes Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Primary Hepatocytes Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Primary Hepatocytes Sales Market Share in Value by Application (2018-2023)
Table 51. Global Primary Hepatocytes Price by Application (2018-2023) & (USD/MT)
Table 52. Global Primary Hepatocytes Sales by Application (2024-2033) & (K MT)
Table 53. Global Primary Hepatocytes Sales Market Share in Volume by Application (2024-2033)
Table 54. Global Primary Hepatocytes Sales by Application (2024-2033) & (US$ Million)
Table 55. Global Primary Hepatocytes Sales Market Share in Value by Application (2024-2033)
Table 56. Global Primary Hepatocytes Price by Application (2024-2033) & (USD/MT)
Table 57. North America Primary Hepatocytes Sales by Application (2018-2023) (K MT)
Table 58. North America Primary Hepatocytes Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Primary Hepatocytes Sales by Application (2018-2023) (K MT)
Table 60. Europe Primary Hepatocytes Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Primary Hepatocytes Sales by Application (2018-2023) (K MT)
Table 62. Asia-Pacific Primary Hepatocytes Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Primary Hepatocytes Sales by Application (2018-2023) (K MT)
Table 64. Latin America Primary Hepatocytes Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Primary Hepatocytes Sales by Application (2018-2023) (K MT)
Table 66. Middle East and Africa Primary Hepatocytes Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 68. North America Primary Hepatocytes Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Primary Hepatocytes Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Primary Hepatocytes Sales Market Share in Value by Country (2018-2023)
Table 71. North America Primary Hepatocytes Sales by Country (2024-2033) & (K MT)
Table 72. North America Primary Hepatocytes Sales Market Share in Volume by Country (2024-2033)
Table 73. North America Primary Hepatocytes Sales by Country (2024-2033) & (US$ Million)
Table 74. North America Primary Hepatocytes Sales Market Share in Value by Country (2024-2033)
Table 75. Europe Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 76. Europe Primary Hepatocytes Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Primary Hepatocytes Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Primary Hepatocytes Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Primary Hepatocytes Sales by Country (2024-2033) & (K MT)
Table 80. Europe Primary Hepatocytes Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe Primary Hepatocytes Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe Primary Hepatocytes Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific Primary Hepatocytes Sales by Region (2018-2023) & (K MT)
Table 84. Asia-Pacific Primary Hepatocytes Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Primary Hepatocytes Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Primary Hepatocytes Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Primary Hepatocytes Sales by Region (2024-2033) & (K MT)
Table 88. Asia-Pacific Primary Hepatocytes Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific Primary Hepatocytes Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific Primary Hepatocytes Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 92. Latin America Primary Hepatocytes Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Primary Hepatocytes Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Primary Hepatocytes Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Primary Hepatocytes Sales by Country (2024-2033) & (K MT)
Table 96. Latin America Primary Hepatocytes Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America Primary Hepatocytes Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America Primary Hepatocytes Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 100. Middle East and Africa Primary Hepatocytes Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Primary Hepatocytes Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Primary Hepatocytes Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Primary Hepatocytes Sales by Country (2024-2033) & (K MT)
Table 104. Middle East and Africa Primary Hepatocytes Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa Primary Hepatocytes Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa Primary Hepatocytes Sales Market Share in Value by Country (2024-2033)
Table 107. Thermo Fisher Scientific, Inc. Company Information
Table 108. Thermo Fisher Scientific, Inc. Introduction and Business Overview
Table 109. Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 110. Thermo Fisher Scientific, Inc. Primary Hepatocytes Product
Table 111. Thermo Fisher Scientific, Inc. Recent Development
Table 112. Merck KGaA Company Information
Table 113. Merck KGaA Introduction and Business Overview
Table 114. Merck KGaA Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 115. Merck KGaA Primary Hepatocytes Product
Table 116. Merck KGaA Recent Development
Table 117. Lonza Company Information
Table 118. Lonza Introduction and Business Overview
Table 119. Lonza Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 120. Lonza Primary Hepatocytes Product
Table 121. Lonza Recent Development
Table 122. Cell Biologics, Inc. Company Information
Table 123. Cell Biologics, Inc. Introduction and Business Overview
Table 124. Cell Biologics, Inc. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 125. Cell Biologics, Inc. Primary Hepatocytes Product
Table 126. Cell Biologics, Inc. Recent Development
Table 127. PromoCell GmbH Company Information
Table 128. PromoCell GmbH Introduction and Business Overview
Table 129. PromoCell GmbH Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 130. PromoCell GmbH Primary Hepatocytes Product
Table 131. PromoCell GmbH Recent Development
Table 132. HemaCare Corporation Company Information
Table 133. HemaCare Corporation Introduction and Business Overview
Table 134. HemaCare Corporation Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 135. HemaCare Corporation Primary Hepatocytes Product
Table 136. HemaCare Corporation Recent Development
Table 137. ZenBio, Inc. Company Information
Table 138. ZenBio, Inc. Introduction and Business Overview
Table 139. ZenBio, Inc. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 140. ZenBio, Inc. Primary Hepatocytes Product
Table 141. ZenBio, Inc. Recent Development
Table 142. STEMCELL Technologies, Inc. Company Information
Table 143. STEMCELL Technologies, Inc. Introduction and Business Overview
Table 144. STEMCELL Technologies, Inc. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 145. STEMCELL Technologies, Inc. Primary Hepatocytes Product
Table 146. STEMCELL Technologies, Inc. Recent Development
Table 147. Corning Incorporated Company Information
Table 148. Corning Incorporated Introduction and Business Overview
Table 149. Corning Incorporated Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 150. Corning Incorporated Primary Hepatocytes Product
Table 151. Corning Incorporated Recent Development
Table 152. AllCells Company Information
Table 153. AllCells Introduction and Business Overview
Table 154. AllCells Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 155. AllCells Primary Hepatocytes Product
Table 156. AllCells Recent Development
Table 157. Axol Bioscience Ltd. Company Information
Table 158. Axol Bioscience Ltd. Introduction and Business Overview
Table 159. Axol Bioscience Ltd. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 160. Axol Bioscience Ltd. Primary Hepatocytes Product
Table 161. Axol Bioscience Ltd. Recent Development
Table 162. iXCells Biotechnologies Company Information
Table 163. iXCells Biotechnologies Introduction and Business Overview
Table 164. iXCells Biotechnologies Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 165. iXCells Biotechnologies Primary Hepatocytes Product
Table 166. iXCells Biotechnologies Recent Development
Table 167. Neuromics Company Information
Table 168. Neuromics Introduction and Business Overview
Table 169. Neuromics Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 170. Neuromics Primary Hepatocytes Product
Table 171. Neuromics Recent Development
Table 172. StemExpress Company Information
Table 173. StemExpress Introduction and Business Overview
Table 174. StemExpress Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 175. StemExpress Primary Hepatocytes Product
Table 176. StemExpress Recent Development
Table 177. BioIVT Company Information
Table 178. BioIVT Introduction and Business Overview
Table 179. BioIVT Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 180. BioIVT Primary Hepatocytes Product
Table 181. BioIVT Recent Development
Table 182. ScienCell Research Laboratories, Inc. Company Information
Table 183. ScienCell Research Laboratories, Inc. Introduction and Business Overview
Table 184. ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 185. ScienCell Research Laboratories, Inc. Primary Hepatocytes Product
Table 186. ScienCell Research Laboratories, Inc. Recent Development
Table 187. PPA Research Group, Inc. Company Information
Table 188. PPA Research Group, Inc. Introduction and Business Overview
Table 189. PPA Research Group, Inc. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 190. PPA Research Group, Inc. Primary Hepatocytes Product
Table 191. PPA Research Group, Inc. Recent Development
Table 192. Creative Bioarray Company Information
Table 193. Creative Bioarray Introduction and Business Overview
Table 194. Creative Bioarray Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 195. Creative Bioarray Primary Hepatocytes Product
Table 196. Creative Bioarray Recent Development
Table 197. BPS Bioscience, Inc. Company Information
Table 198. BPS Bioscience, Inc. Introduction and Business Overview
Table 199. BPS Bioscience, Inc. Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 200. BPS Bioscience, Inc. Primary Hepatocytes Product
Table 201. BPS Bioscience, Inc. Recent Development
Table 202. Epithelix Sàrl Company Information
Table 203. Epithelix Sàrl Introduction and Business Overview
Table 204. Epithelix Sàrl Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 205. Epithelix Sàrl Primary Hepatocytes Product
Table 206. Epithelix Sàrl Recent Development
Table 207. ReachBio LLC Company Information
Table 208. ReachBio LLC Introduction and Business Overview
Table 209. ReachBio LLC Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 210. ReachBio LLC Primary Hepatocytes Product
Table 211. ReachBio LLC Recent Development
Table 212. AcceGen Company Information
Table 213. AcceGen Introduction and Business Overview
Table 214. AcceGen Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 215. AcceGen Primary Hepatocytes Product
Table 216. AcceGen Recent Development
Table 217. Sekisui XenoTech, LLC Company Information
Table 218. Sekisui XenoTech, LLC Introduction and Business Overview
Table 219. Sekisui XenoTech, LLC Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 220. Sekisui XenoTech, LLC Primary Hepatocytes Product
Table 221. Sekisui XenoTech, LLC Recent Development
Table 222. Biopredic International Company Information
Table 223. Biopredic International Introduction and Business Overview
Table 224. Biopredic International Primary Hepatocytes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 225. Biopredic International Primary Hepatocytes Product
Table 226. Biopredic International Recent Development
Table 227. Key Raw Materials Lists
Table 228. Raw Materials Key Suppliers Lists
Table 229. Primary Hepatocytes Market Trends
Table 230. Primary Hepatocytes Market Drivers
Table 231. Primary Hepatocytes Market Challenges
Table 232. Primary Hepatocytes Market Restraints
Table 233. Primary Hepatocytes Distributors List
Table 234. Primary Hepatocytes Downstream Customers
Table 235. Research Programs/Design for This Report
Table 236. Key Data Information from Secondary Sources
Table 237. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Hepatocytes Product Picture
Figure 2. Global Primary Hepatocytes Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Primary Hepatocytes Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Primary Hepatocytes Sales Status and Outlook (2018-2033) & (K MT)
Figure 5. Product Picture of Human Primary Cells
Figure 6. Global Human Primary Cells Sales YoY Growth (2018-2033) & (K MT)
Figure 7. Product Picture of Animal Primary Cells
Figure 8. Global Animal Primary Cells Sales YoY Growth (2018-2033) & (K MT)
Figure 9. Global Primary Hepatocytes Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global Primary Hepatocytes Sales Market Share by Type in 2022 & 2033
Figure 11. North America Primary Hepatocytes Sales Market Share in Volume by Type in 2022
Figure 12. North America Primary Hepatocytes Sales Market Share in Value by Type in 2022
Figure 13. Europe Primary Hepatocytes Sales Market Share in Volume by Type in 2022
Figure 14. Europe Primary Hepatocytes Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Primary Hepatocytes Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Primary Hepatocytes Sales Market Share in Value by Type in 2022
Figure 17. Latin America Primary Hepatocytes Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Primary Hepatocytes Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Primary Hepatocytes Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Primary Hepatocytes Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Primary Hepatocytes Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Primary Hepatocytes Revenue in 2022
Figure 23. Primary Hepatocytes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Life Science Research Companies
Figure 25. Global Life Science Research Companies Sales YoY Growth (2018-2033) & (K MT)
Figure 26. Product Picture of Research Institutes
Figure 27. Global Research Institutes Sales YoY Growth (2018-2033) & (K MT)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2033) & (K MT)
Figure 30. Global Primary Hepatocytes Sales by Application (2018-2033) & (US$ Million)
Figure 31. Global Primary Hepatocytes Sales Market Share by Application in 2022 & 2033
Figure 32. North America Primary Hepatocytes Sales Market Share in Volume by Application in 2022
Figure 33. North America Primary Hepatocytes Sales Market Share in Value by Application in 2022
Figure 34. Europe Primary Hepatocytes Sales Market Share in Volume by Application in 2022
Figure 35. Europe Primary Hepatocytes Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Primary Hepatocytes Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Primary Hepatocytes Sales Market Share in Value by Application in 2022
Figure 38. Latin America Primary Hepatocytes Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Primary Hepatocytes Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Primary Hepatocytes Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Primary Hepatocytes Manufacturing Cost Structure
Figure 43. Primary Hepatocytes Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed